[1]Patent:US2005/261289,2005,A1,.Locationinpatent:Page/Pagecolumn7
[1]Patent:US2005/261289,2005,A1.Locationinpatent:Page/Pagecolumn7
[1]InternationalJournalofMedicinalChemistry,2017,vol.2017
[1]InternationalJournalofMedicinalChemistry,2017,vol.2017
[1]Yuan,Gengyang;Jankins,TannerC.;Patrick,ChristopherG.;Philbrook,Phaethon;Sears,Olivia;Hatfield,Stephen;Sitkovsky,Michail;Vasdev,Neil;Liang,StevenH.;Ondrechen,MaryJo;Pollastri,MichaelP.;Jones,GrahamB.[InternationalJournalofMedicinalChemistry,2017,vol.2017]
Title: Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
Journal: The Lancet. Neurology 20140801
Title: Adenosine A2A receptor as a drug discovery target.
Journal: Journal of medicinal chemistry 20140508
Title: Quantification of indirect pathway inhibition by the adenosine A2a antagonist SYN115 in Parkinson disease.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience 20101201
Title: Olivier Barret, et al. Adenosine 2A Receptor Occupancy by Tozadenant and Preladenant in Rhesus Monkeys. J Nucl Med. 2014 Oct;55(10):1712-8.